Don’t miss the Innovative Technologies Plenary Session, Presidential Select Symposium, and more, say Program Committee Chairs Lillian L. Siu, MD, FAACR, and Matthew G. Vander Heiden, MD, PhD.

Tuesday’s plenary presentations will explore how new insights into dynamic relationships are opening the door to novel therapeutic strategies aimed at disrupting cancer’s supportive environment.

Four distinguished experts in cancer immunology, small cell lung cancer, multigene sequencing, and molecular epidemiology will present during unique sessions Monday evening.

A series of three scientific sessions will explore the early detection of cancer and the interception of new tumors, progressive disease, and recurrent lesions.

Don’t miss the Opening Ceremony and Opening Plenary, the first sessions of the highly anticipated clinical trials plenary program, and more, say Program Committee Chairs Lillian L. Siu, MD, FAACR, and Matthew G. Vander Heiden, MD, PhD.

AACR President Patricia M. LoRusso, DO, PhD (hc), FAACR, will address efforts to accelerate research and advance personalized medicine around the world.

Today’s Plenary Session will expand on this year’s meeting theme, revolving around the concept of carrying scientific discoveries through to impactful therapeutics.

Exciting clinical trials will be presented across four Clinical Trials Plenary Sessions and three Clinical Trials Minisymposia, each highlighting advances in a specific subject area.

Monday’s plenary platform will present four technologies helping to chart new horizons in oncology by advancing our understanding of cancer and developing better therapies for patients.

This three-part series will delve into behind-the-scenes strategies in oncology drug design and development, offering expert insight into the next-generation landscape.